谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase 3, Randomized, Open-Label Study of Upfront Camizestrant Vs Standard Endocrine Therapy As Adjuvant Treatment for ER-positive/HER2negative Early Breast Cancer with Intermediate-High or High Risk of Recurrence (CAMBRIA-2)

Sibylle Loibl,Yeon Park,Sara Tolaney,Ioanna Gioni,Simon Johnston,Teresa Klinowska,Ingrid A. Mayer,Raquel Nunes,Barbara Pistilli,Mary Stuart,Angela Quintana,Andrew Walding,Michael Gnant

CANCER RESEARCH（2024）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要